Skip to content
OpenCapital
Get started

John Wiley & Sons, Inc. WLY Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By product

See full
Research Publishing88%+7.3%
Academic49%-10.9%
Research Solutions48%-15.8%
Digital Courseware35%+6.1%
Professional1%—

Other financials

Income statement

See full
Revenue$447.9M+1.2%
Gross profit$337.9M+1.9%
Operating income$110.1M+44.0%
Net income$135.3M+98.8%
EPS (diluted)$2.54+105%

Balance sheet

See full
Cash & equivalents$75.6M-11.9%
Total debt$768.9M-14.5%
Total equity$848.2M+12.8%
Total assets$2.6B-3.7%

Cash flow

See full
Operating cash flow$157.2M+4.6%
CapEx$13.2M-31.1%
Free cash flow$144.0M+9.8%

Valuation

See full
Market cap$2.31B-1.0%
Enterprise value$3.01B-4.6%
P/E10.4×-17.3×
P/S1.4×0.0×

Profitability

See full
Gross margin74.3%0.0pp
Operating margin16.5%+3.3pp
Net margin13.2%+8.2pp
FCF margin12.5%+4.1pp

Returns & leverage

See full
Return on equity27.7%+16.4pp
Debt / equity0.9×-0.3×
Current ratio0.5×0.0×